US Supreme Court sides with Teva in drug dispute
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva shares tumble amid political battle, doubt from Moody's
Teva Pharmaceuticals gets a coronavirus boost, but it won't last long - Business - Haaretz.com
Shloma Yanai (R), CEO of Teva Pharmaceutical Industries Ltd. and Hans-Joachim Ziems, chairman of VEM Holding exchange a handshake prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on
Teva Pharmaceutical Industries Ltd | Reuters
Teva Stops Production At US Plant After FDA Concerns: Report
Teva buys Anda for $500 million - ISRAEL21c
Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | FiercePharma
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OMAQFWFHNJDZCDZKKO5DWLBG4.jpg "Teva Israel enters medical cannabis market with new partnership | Reuters")
Teva Israel enters medical cannabis market with new partnership | Reuters
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharm woes seen denting Israeli exports, economic growth By Reuters
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Teva Pharmaceutical Industries Ltd | Reuters
GSK's $235 million verdict revived against Teva, again | Reuters.com
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
Teva stock plummets 18% after rough quarter in US generic drug market
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
